Article PDF
References
McEvoy G . AHFS drug information. Authority of the Board of the American Society Health System Pharmacy, 2000::2513–4, 2532-3.
Foster CS, Alter G, De Barge LR, et al. Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis. Am J Ophthalmol 1996;122:171–82.
Leibowitz HM, Bartlett JD, Rich R, McQuirter H, Stewart R, Assil K . Intraocular pressure raising potential of 1% rimexolone in patients responding to corticosteroids. Arch Ophthalmol 1996;114:933–7.
Johnson D, Gottanka J, Flugel C, et al. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 1997;115:375–83.
Rohen JW, Linner E, Witner R . Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid glaucoma. Exp Eye Res 1973;17:1931.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cazabon, S., Morrell, A. Rimexolone-induced intraocular pressure elevation. Eye 15, 663–664 (2001). https://doi.org/10.1038/eye.2001.209
Issue Date:
DOI: https://doi.org/10.1038/eye.2001.209